4
Changes in Ownership
NewAmsterdam Pharma Co N.V. Filed Acc 0000950170-25-042176
Chief Operating Officer sold 100,000 shares
- Chief Operating Officer acquired 100,000 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Kling Douglas F Chief Operating Officer | 2025-03-17 | Option exercise 10b5-1 | +88,112 | 132,112 | D | ||
| Kling Douglas F Chief Operating Officer | 2025-03-17 | Option exercise 10b5-1 | +11,888 | $10.00 | $118,880 | 144,000 | D |
| Kling Douglas F Chief Operating Officer | 2025-03-17 | Sale 10b5-1 | −100,000 | 44,000 | D | ||
| Derivatives | |||||||
| Kling Douglas F Chief Operating Officer | 2025-03-17 | Option exercise · Option (right to buy) 10b5-1 | −88,112 | 47,251 | D | ||
| Kling Douglas F Chief Operating Officer | 2025-03-17 | Option exercise · Option (right to buy) 10b5-1 | −11,888 | 650,930 | D | ||
| Open-market sales · 100,000 sh | |||||||
Loading xslF345X05/ownership.xml…